schizophrenia - modifying: antipsychotic: social implications

Question 1

freedom

Answer 1

P: A key social strength of antipsychotic medication is that it has enabled individuals with schizophrenia to live outside mental asylums, which were often inhumane and isolating.
E: Prior to the widespread use of antipsychotic medication in the 1950s, people with schizophrenia were commonly institutionalized in overcrowded asylums where they faced deplorable conditions, including forced restraints and unethical treatments like electroconvulsive therapy without consent (Scull, 2015). With the advent of medication, many individuals now manage their symptoms effectively enough to reintegrate into society.
T: This is a significant social benefit as it restores dignity and autonomy to patients, allowing them to live relatively normal lives and contribute to society, including through employment, which also benefits the economy.
C: However, critics argue that community care systems are often underfunded, leaving some individuals without adequate support, which can lead to homelessness or re-hospitalization

Question 2

societal stigma

Answer 2

P: While antipsychotic medication allows for better symptom management, it has not fully eliminated the stigma associated with schizophrenia, which can hinder social inclusion.
E: Research shows that over 60% of people with schizophrenia report experiencing discrimination in employment, housing, and social relationships even when their symptoms are well-managed (Thornicroft et al., 2009).
T: This highlights a social weakness, as the reliance on medication alone does not address societal misconceptions or biases, limiting patients’ opportunities for genuine social integration.
COUNTER: Advocates might argue that increased public awareness and education campaigns alongside medication have started to reduce stigma over time. Perhaps it is only a matter of time before this stigma is gone

Question 3

reduction of burden

Answer 3

P: Antipsychotic medication reduces the strain on family members and caregivers by managing the symptoms of schizophrenia, thereby improving social relationships.
E: A study by Magliano et al. (2005) found that families reported a significant decrease in stress and an improvement in family dynamics when patients adhered to antipsychotic treatment, as symptoms like aggression and paranoia were mitigated.
T: This is a social strength as it not only improves the well-being of the patient but also fosters healthier social environments and reduces caregiver burnout.
COUNTER: Critics might argue that the emotional toll on families remains significant, particularly when patients experience severe side effects or non-adherence to medication.